Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-07-29 1:13 pm Purchase | 2025-06-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | VANGUARD GROUP INC | 3,318,383 5.540% | 3,318,383![]() (New Position) | Filing History |
2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BlackRock Inc. BLK | 3,252,910 5.400% | 3,252,910![]() (New Position) | Filing History |
2025-02-14 5:34 pm Purchase | 2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | ARMISTICE CAPITAL LLC | 3,137,553 4.990% | 773,553![]() (+32.72%) | Filing History |
2025-02-14 11:22 am Sale | 2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Frazier Life Sciences Public Fund, L.P. | 1,176,735 2.000% | -2,384,909![]() (-66.96%) | Filing History |
2024-11-14 4:51 pm Sale | 2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | ARMISTICE CAPITAL LLC | 2,364,000 5.960% | -78,742![]() (-3.22%) | Filing History |
2024-11-05 4:17 pm Purchase | 2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN | RA CAPITAL MANAGEMENT L.P. | 3,566,338 6.100% | 3,566,338![]() (New Position) | Filing History |
2024-11-05 11:44 am Purchase | 2024-10-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Frazier Life Sciences Public Fund, L.P. | 3,561,644 6.100% | 3,561,644![]() (New Position) | Filing History |
2024-10-31 5:50 pm Unchanged | 2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% | 0 (Unchanged) | Filing History |
2024-10-31 5:49 pm Purchase | 2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% | 1,966,572![]() (+45.45%) | Filing History |
2024-02-14 3:35 pm Purchase | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | ARMISTICE CAPITAL LLC | 2,442,742 9.990% | 2,442,742![]() (New Position) | Filing History |
2024-02-14 3:01 pm Unchanged | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Cormorant Asset Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
2024-02-14 10:06 am Purchase | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 4,326,710 17.900% | 2,000,000![]() (+85.96%) | Filing History |
2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Cormorant Asset Management LP | 1,391,663 9.990% | -36,935![]() (-2.59%) | Filing History |
2022-02-14 3:00 pm Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Cormorant Asset Management LP | 1,428,598 9.900% | 1,428,598![]() (New Position) | Filing History |
2022-02-11 07:20 am Purchase | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Woodline Partners LP | 685,273 4.800% | 685,273![]() (New Position) | Filing History |
2022-02-10 09:01 am Unchanged | 2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Eledon Pharmaceuticals, Inc. ELDN | FMR LLC | 504,371 3.525% | 504,371![]() (New Position) | Filing History |
2022-01-28 4:35 pm Purchase | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% | 878,690![]() (+60.68%) | Filing History |
2022-01-26 4:27 pm Sale | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 0 0.000% | -1,339,793![]() (Position Closed) | Filing History |
2022-01-10 5:57 pm Purchase | 2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% | 13,088![]() (+0.91%) | Filing History |